Valuation estimate, page-128

The analysis on here is fine but it reminds me when I was holding the classic A2M under $2 and I was running my forward Estimates while others were just trying to value them quarter to quarter. Good luck trying to do that you will never be on top of the game. Running forward PE analysis and earnings and running off a higher PE due to its growth rate is the way to go for zoono right now and it does include some guestimates but that’s how the real money is made. A2Ms growth was all driven from one country being China. Zoono growth is being driven world wide and is just beginning to enter many countries. Covid is not slowing down. The prior analysis is only valid if you think growth can’t continue in terms of earnings and they just hit a full stop which just isn’t going to happen.